LUCD — Lucid Diagnostics Share News
0.000.00%
Last trade - 00:00- $206.03m
- $213.49m
- $4.71m
Lucid Diagnostics Inc expected to post a loss of 26 cents a share - Earnings Preview
Lucid Diagnostics Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: PAVmed Issued Information Statement Relating To Distribution To Stockholders Of About 3.3 Mln Shares Of Lucid Diagnostics
Brief: PAVmed Elected To Receive $4.7 Million Fees & Reimbursements From Lucid Diagnostics
U.S. RESEARCH ROUNDUP- Cigna Group, Datadog, Landstar System
Brief: Lucid Diagnostics says Shaun M. O'neil Will Now Serve As President And Chief Operating Officer
U.S. RESEARCH ROUNDUP-Beauty Health, Design Therapeutics, Energizer Holdings
Brief: Lucid Diagnostics Launches EsoGuard Esophageal DNA Test
U.S. RESEARCH ROUNDUP-Aerovironment, Hubspot, Oracle
Lucid Diagnostics Inc reports results for the quarter ended in June - Earnings Summary
Lucid Diagnostics Inc expected to post a loss of 32 cents a share - Earnings Preview
Brief: PAVmed And Lucid's Chairman And CEO Lishan Aklog Testifies At U.S. House Of Representatives Energy And Commerce Committee
U.S. RESEARCH ROUNDUP- Kenvue, Universal Health Services, Workday
Brief: Lucid Diagnostics Files Prospectus For Potential Offer, Sale Of 25.69 Million Shares Of Common Stock, By Selling Stockholder - SEC Filing
U.S. RESEARCH ROUNDUP-Magellan Midstream Partners LP, Onsemi, Viking Therapeutics
Brief: Pavmed Inc - QTRLY Non-GAAP Adjusted Loss Per Share $0.10
Brief: Ayrton Capital Reports 9.99% Passive Stake In Lucid Diagnostics
Brief: Lucid Diagnostics Says Qtrly Loss Per Share $0.47
Lucid Diagnostics Inc reports results for the quarter ended in December - Earnings Summary